BibTex RIS Cite

-

Year 2014, Volume: 36 Issue: 1, 77 - 82, 28.03.2014
https://doi.org/10.7197/cmj.v36i1.1008002383

Abstract

Aim. To evaluate our glaucoma tube implantation results for glaucoma cases that cannot be controlled with medication therapy. Method. The records of 31 cases whose medical records could be reached and and who could come to regular follow up visits among 123 patients that applied to our clinic between January 2004-January 2011 with refractory glaucoma for medical therapy were evaluated retrospectively. Results. Glaucoma tube implantation was performed with diagnosis of neovascular glaucoma in 24 cases, uveitic glaucoma in 4 cases, aphakic glaucoma in 2 cases, pseudoexfoliation glaucoma in 1 case. Ahmed valve for 25 cases, Molteno for 3 cases, Baerveldt for 2 cases, keiki mehta for one case were implanted. Preoperative intraocular pressure median value was 40 mmHg (23-66).The median value of follow up duration was found to be 10 months (3-78). The median value of intraocular pressures for last follow up visit was 15.5 mmHg (6-67). As postoperative complications, chronic hyphema in 3 cases, hypotony and hyphema in 1 case, hypotony and following phthisis bulbi in 1 case, painful eye and following evisceration in 1 case, epiretinal membrane in 1 case, endothelial failure in 1 case were observed. Conclusion. Glaucoma tube implantation is efficient alternative treatment method for refractory.

References

  • Yalvaç IS, Kulaçoğlu DN. Glokom cerrahisinde seton implantları. Glo-Kat 2008; 3: 63Kim J, Allingham RR, Hall J, Klitzman B, Stinnett S, Asrani S. Clinical experience with a novel glaucoma drainage implant. J Glaucoma 2014; 23: 91-7. Souza C, Tran DH, Loman J, Law SK, Coleman AL, Caprioli J. Long-term outcomes of Ahmed glaucoma valve implantation in refractory glaucomas. Am J Ophthalmol 2007; 144: 893-900.
  • Broadway DC, Iester M, Schulzer M, Douglas GR. Survival analysis for success of Molteno tube implants. Br J Ophthalmol 2001; 85: 689-95.
  • Budenz DL, Barton K, Feuer WJ, Schiffman J, Costa VP, Godfrey DG, Buys YM; Ahmed Baerveldt Comparison Study Group. Ahmed Baerveldt Comparison Study Group. Treatment outcomes in the Ahmed Baerveldt comparison study after 1 year of follow-up. Ophthalmology 2011; 118: 443-52.
  • Aksoy NÖ, Yalvaç IS, Şatana B, Ekşioğlu Ü, Kasım R, Aslan BS, Duman S. Alt kadrana yerleştirilen glokom implantları klinik uygulama sonuçları. TJO 2008; 38: 191-7.
  • Tsai JC, Feuer WJ, Parrish RK 2nd, Grajewski AL. 5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of the original pilot study. Ophthalmology 1995; 102: 887-92.
  • Kaya M, Ozbek Z, Yaman A, Durak I. Long-term success of Ahmed glaucoma valve in refractory glaucoma. Int J Ophthalmol 2012; 5: 108-12.
  • Yalvac IS, Eksioglu U, Satana B, Duman S. Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma. Eye (Lond) 2007; 21: 65-70.
  • Taşkapılı M, Yılmazlı C, Kocabora S, Şerefoğlu K, Özsütçü M, Göçmez E. Neovasküler Glokom Olgularında Polipropilen ve Silikon Ahmed Glokom Valvlerinin Karşılaştırmas. Glo-Kat 2008; 3: 37-41.
  • Faghihi H, Hajizadeh F, Mohammadi SF, Kadkhoda A, Peyman GA, RiaziEsfahani M. Pars plana Ahmed valve implant and vitrectomy in the management of neovascular glaucoma. Ophthalmic Surg Lasers Imaging 2007; 38: 292-300.
  • Kayıkçıoğlu Ö, Seymenoğlu G, Cinali M. Dirençli Glokomlarda Pars Plana Vitrektomi ile Kombine Pars Plana Molteno Tüp İmplantasyonu. Glo-Kat 2010; 5: 160-4.
  • Kaynak S, Tekin NF, Durak I, Berk AT, Saatci AO, Soylev MF. Pars plana vitrectomy with pars plana tube implantation in eyes with intractable glaucoma. Br J Ophthalmol 1998; 82: 1377-82.
  • Scott IU, Alexandrakis G, Flynn HW Jr, Smiddy WE, Murray TG, Schiffman J, Gedde SJ, Budenz DL, Fantes F, Parrish RK. Combined pars plana vitrectomy and glaucoma drainage implant placement for refractory glaucoma. Am J Ophthalmol 2000; 129: 334-41.
  • Lim KS, Allan BD, Lloyd AW, Muir A, Khaw PT. Glaucoma drainage devices; past, present, and future. Br J Ophthalmol 1998; 82: 1083-9. de Guzman MH, Valencia A, Farinelli AC. Pars plana insertion of glaucoma drainage devices for refractory glaucoma. Clin Experiment Ophthalmol 2006; 34: 102Suárez-Fernández MJ, Gutiérrez-Díaz E, Julve San Martín A, Fernández-Reyes MF, Mencía-Gutiérrez E. Simultaneous pars plana vitrectomy and glaucoma drainage device implant. Arch Soc Esp Oftalmol 2010; 85: 97-102.
  • Acar BT, Hamurcu M, Sevim MŞ, Acar S. Tedaviye Dirençli Glokomda Ahmed Glokom Valfi İmplantasyonu. Glo-Kat 2010; 5: 189-94.
  • Da Mata A, Burk SE, Netland PA, Baltatzis S, Christen W, Foster CS. Management of uveitic glaucoma with Ahmed glaucoma valve implantation. Ophthalmology 1999; 106: 2168-72.
  • Vuori ML. Molteno aqueous shunt as a primary surgical intervention for uveitic glaucoma: Long-term results. Acta Ophthalmol 2010; 88: 33-6.
  • Ozdal PC, Vianna RN, Deschenes J. Ahmed valve implantation in glaucoma secondary to chronic uveitis. Eye (Lond) 2006; 20: 178-83.
  • Shen CC, Salim S, Du H, Netland PA. Trabeculectomy versus Ahmed Glaucoma Valve implantation in neovascular glaucoma. Clin Ophthalmol 2011; 5: 281-6.

Tedaviye dirençli glokom olgularında seton implantasyonu sonuçlarımız

Year 2014, Volume: 36 Issue: 1, 77 - 82, 28.03.2014
https://doi.org/10.7197/cmj.v36i1.1008002383

Abstract

Özet

Amaç. Medikal tedavi ile kontrol altına alınamayan glokomlarda seton implantasyonu sonuçlarını değerlendirmek. Yöntem. Kliniğimizde, Ocak 2004-Ocak 2011 tarihleri arasında medikal tedaviyle kontrol altına alınamayıp seton implantasyonu yapılan 123 glokom hastasından, dosya bilgilerine ulaşılan ve düzenli takiplerine gelen 31 olgunun dosya bilgileri retrospektif olarak incelenmiştir. Bulgular. 24 olguya neovasküler glokom, 4 olguya üveitik glokom, 2 olguya afakik glokom, 1 olguya psödoeksfolyatif glokom tanısı ile seton implantasyonu yapılmıştır. 25 olguda Ahmed, 3 olguda Molteno, 2 olguda Baerveldt, 1 olguda Keiki Mehta implantı kullanılmıştır. Ameliyat öncesi göz içi basıncı ortanca değeri 40 mmHg (23-66) olarak bulunmuştur. Olguların takip sürelerinin ortanca değeri 10 ay (3-78) olarak saptanmıştır. Son kontroldeki GİB ortanca değeri 15,5 mmHg (6-67) olarak bulunmuştur. Ameliyat sonrası komplikasyonlar; 3 olguda kronik hifema, 1 olguda hifema ve hipotoni, bir olguda hipotoni ve sonrasında ftizis bulbi, 1 olguda ağrılı göz nedeni ile evisserasyon, 1 olguda epiretinal membran, 1 olguda lokalize endotelyal yetmezlik görülmüştür. Sonuç. Seton implantasyonu medikal tedaviye dirençli glokom olgularında etkili bir tedavi yöntemidir.

Anahtar sözcükler: glokom, seton implantları

 

Abstract

Aim. To evaluate our glaucoma tube implantation results for glaucoma cases that cannot be controlled with medication therapy. Method. The records of 31 cases whose medical records could be reached and and who could come to regular follow up visits among 123 patients that applied to our clinic between January 2004-January 2011 with refractory glaucoma for medical therapy were evaluated retrospectively. Results. Glaucoma tube implantation was performed with diagnosis of neovascular glaucoma in 24 cases, uveitic glaucoma in 4 cases, aphakic glaucoma in 2 cases, pseudoexfoliation glaucoma in 1 case. Ahmed valve for 25 cases, Molteno for 3 cases, Baerveldt for 2 cases, keiki mehta for one case were implanted. Preoperative intraocular pressure median value was 40 mmHg (23-66).The median value of follow up duration was found to be 10 months (3-78). The median value of intraocular pressures for last follow up visit was 15.5 mmHg (6-67). As postoperative complications, chronic hyphema in 3 cases, hypotony and hyphema in 1 case, hypotony and following phthisis bulbi in 1 case, painful eye and following evisceration in 1 case, epiretinal membrane in 1 case, endothelial failure in 1 case were observed. Conclusion. Glaucoma tube implantation is efficient alternative treatment method for refractory.

Keywords: Glaucoma, seton implants

References

  • Yalvaç IS, Kulaçoğlu DN. Glokom cerrahisinde seton implantları. Glo-Kat 2008; 3: 63Kim J, Allingham RR, Hall J, Klitzman B, Stinnett S, Asrani S. Clinical experience with a novel glaucoma drainage implant. J Glaucoma 2014; 23: 91-7. Souza C, Tran DH, Loman J, Law SK, Coleman AL, Caprioli J. Long-term outcomes of Ahmed glaucoma valve implantation in refractory glaucomas. Am J Ophthalmol 2007; 144: 893-900.
  • Broadway DC, Iester M, Schulzer M, Douglas GR. Survival analysis for success of Molteno tube implants. Br J Ophthalmol 2001; 85: 689-95.
  • Budenz DL, Barton K, Feuer WJ, Schiffman J, Costa VP, Godfrey DG, Buys YM; Ahmed Baerveldt Comparison Study Group. Ahmed Baerveldt Comparison Study Group. Treatment outcomes in the Ahmed Baerveldt comparison study after 1 year of follow-up. Ophthalmology 2011; 118: 443-52.
  • Aksoy NÖ, Yalvaç IS, Şatana B, Ekşioğlu Ü, Kasım R, Aslan BS, Duman S. Alt kadrana yerleştirilen glokom implantları klinik uygulama sonuçları. TJO 2008; 38: 191-7.
  • Tsai JC, Feuer WJ, Parrish RK 2nd, Grajewski AL. 5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of the original pilot study. Ophthalmology 1995; 102: 887-92.
  • Kaya M, Ozbek Z, Yaman A, Durak I. Long-term success of Ahmed glaucoma valve in refractory glaucoma. Int J Ophthalmol 2012; 5: 108-12.
  • Yalvac IS, Eksioglu U, Satana B, Duman S. Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma. Eye (Lond) 2007; 21: 65-70.
  • Taşkapılı M, Yılmazlı C, Kocabora S, Şerefoğlu K, Özsütçü M, Göçmez E. Neovasküler Glokom Olgularında Polipropilen ve Silikon Ahmed Glokom Valvlerinin Karşılaştırmas. Glo-Kat 2008; 3: 37-41.
  • Faghihi H, Hajizadeh F, Mohammadi SF, Kadkhoda A, Peyman GA, RiaziEsfahani M. Pars plana Ahmed valve implant and vitrectomy in the management of neovascular glaucoma. Ophthalmic Surg Lasers Imaging 2007; 38: 292-300.
  • Kayıkçıoğlu Ö, Seymenoğlu G, Cinali M. Dirençli Glokomlarda Pars Plana Vitrektomi ile Kombine Pars Plana Molteno Tüp İmplantasyonu. Glo-Kat 2010; 5: 160-4.
  • Kaynak S, Tekin NF, Durak I, Berk AT, Saatci AO, Soylev MF. Pars plana vitrectomy with pars plana tube implantation in eyes with intractable glaucoma. Br J Ophthalmol 1998; 82: 1377-82.
  • Scott IU, Alexandrakis G, Flynn HW Jr, Smiddy WE, Murray TG, Schiffman J, Gedde SJ, Budenz DL, Fantes F, Parrish RK. Combined pars plana vitrectomy and glaucoma drainage implant placement for refractory glaucoma. Am J Ophthalmol 2000; 129: 334-41.
  • Lim KS, Allan BD, Lloyd AW, Muir A, Khaw PT. Glaucoma drainage devices; past, present, and future. Br J Ophthalmol 1998; 82: 1083-9. de Guzman MH, Valencia A, Farinelli AC. Pars plana insertion of glaucoma drainage devices for refractory glaucoma. Clin Experiment Ophthalmol 2006; 34: 102Suárez-Fernández MJ, Gutiérrez-Díaz E, Julve San Martín A, Fernández-Reyes MF, Mencía-Gutiérrez E. Simultaneous pars plana vitrectomy and glaucoma drainage device implant. Arch Soc Esp Oftalmol 2010; 85: 97-102.
  • Acar BT, Hamurcu M, Sevim MŞ, Acar S. Tedaviye Dirençli Glokomda Ahmed Glokom Valfi İmplantasyonu. Glo-Kat 2010; 5: 189-94.
  • Da Mata A, Burk SE, Netland PA, Baltatzis S, Christen W, Foster CS. Management of uveitic glaucoma with Ahmed glaucoma valve implantation. Ophthalmology 1999; 106: 2168-72.
  • Vuori ML. Molteno aqueous shunt as a primary surgical intervention for uveitic glaucoma: Long-term results. Acta Ophthalmol 2010; 88: 33-6.
  • Ozdal PC, Vianna RN, Deschenes J. Ahmed valve implantation in glaucoma secondary to chronic uveitis. Eye (Lond) 2006; 20: 178-83.
  • Shen CC, Salim S, Du H, Netland PA. Trabeculectomy versus Ahmed Glaucoma Valve implantation in neovascular glaucoma. Clin Ophthalmol 2011; 5: 281-6.
There are 18 citations in total.

Details

Primary Language Turkish
Journal Section Surgical Science Research Articles
Authors

Raşit Kılıç

Ertuğrul Mirza

Kuddusi Erkılıç

Sarper Karaküçük

Osman Polat

Ayşe Öner

Publication Date March 28, 2014
Published in Issue Year 2014Volume: 36 Issue: 1

Cite

AMA Kılıç R, Mirza E, Erkılıç K, Karaküçük S, Polat O, Öner A. Tedaviye dirençli glokom olgularında seton implantasyonu sonuçlarımız. CMJ. March 2014;36(1):77-82. doi:10.7197/cmj.v36i1.1008002383